Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amphotericin B-associated hypertension

Y Le1, K Z Rana, M N Dudley

  • 1Department of Pharmacy, Veterans Administration Medical Center, Providence, RI, USA.

The Annals of Pharmacotherapy
|July 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oral health-related quality of life of patients with class II and class III dentofacial deformity before and after orthognathic surgery: a prospective cohort study.

International journal of oral and maxillofacial surgery·2026
Same author

Pericoronary adipose tissue attenuation predicts outcome of percutaneous intervention for chronic total occlusion.

Clinical radiology·2023
Same author

Pharmacokinetic-Pharmacodynamic Target Attainment Analyses as Support for Meropenem-Vaborbactam Dosing Regimens and Susceptibility Breakpoints.

Antimicrobial agents and chemotherapy·2022
Same author

[Langerhans cell histiocytosis involving pituitary and thyroid gland: a case report].

Zhonghua nei ke za zhi·2022
Same author

Population Pharmacokinetics of Meropenem and Vaborbactam Based on Data from Noninfected Subjects and Infected Patients.

Antimicrobial agents and chemotherapy·2021
Same author

Modeling and predicting osteoarthritis progression: data from the osteoarthritis initiative.

Osteoarthritis and cartilage·2018
Same journal

Prolonged Response to Nivolumab in Metastatic Vulvar Carcinoma: Should Immunotherapy be Continued and for How Long? A Debatable Issue!

The Annals of pharmacotherapy·2026
Same journal

Stability of Ceftazidime-Avibactam: Changes in Regulatory Information and Implications for Preparation.

The Annals of pharmacotherapy·2026
Same journal

Impact of Early Dose Adjustment of Piperacillin/Tazobactam on Mortality in Critically Ill Patients With Acute Kidney Injury: A Retrospective Multicenter Cohort Study.

The Annals of pharmacotherapy·2026
Same journal

Severe Phototoxic Skin Reaction Associated With Vandetanib: Implications for Pharmaceutical Care.

The Annals of pharmacotherapy·2026
Same journal

Efficacy and Safety of Oral PCSK9 Inhibitors in Adults With Hypercholesterolemia: An Updated Systematic Review and Meta-Analysis of RCTs.

The Annals of pharmacotherapy·2026
Same journal

RSVpreF: A Vaccine for the Respiratory Syncytial Virus.

The Annals of pharmacotherapy·2026
See all related articles

Amphotericin B infusion can cause sudden hypertension in patients. Stopping the infusion quickly resolves high blood pressure, suggesting a direct link between the drug and these episodes.

Area of Science:

  • Mycology
  • Pharmacology
  • Nephrology

Background:

  • Amphotericin B is a critical antifungal medication used for severe systemic fungal infections.
  • Hypertension is a potential adverse effect of various medications, requiring careful patient monitoring.

Observation:

  • Two patients developed acute hypertension within minutes of initiating amphotericin B infusions.
  • Blood pressure normalized rapidly upon cessation of amphotericin B administration in both cases.

Findings:

  • A potential causal relationship between amphotericin B and hypertensive episodes is suggested.
  • The exact mechanism remains unclear, possibly involving drug-induced vasoconstriction or pre-infusion saline administration.

Implications:

Related Experiment Videos

  • Clinicians should monitor blood pressure closely during amphotericin B therapy.
  • Administering intravenous NaCl 0.9% after amphotericin B and discontinuing infusion if hypertension occurs are recommended management strategies.